Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT05445609 · SUSPENDED

Trial details

NCT number: NCT05445609
Sponsor: Emory University
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Adenocarcinoma Stage IV Prostate Cancer AJCC v8

Start date: 2023-06-07
Primary completion: 2027-06-23
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.